Investigational drug

DRUG7 trials

Sponsors

Merck Sharp & Dohme LLC, Pfizer, Celgene Corporation, Hasanuddin University, Sun Pharmaceutical Industries Limited

Conditions

Actinic Keratosis (AK)Alzheimer DiseaseCOVID-19Carcinoma, Non-Small-Cell LungColorectal NeoplasmsDiarrheaHypoalbuminemiaLung Neoplasms

Phase 1

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

CompletedNCT00036140

PfizerMultiple Myeloma

Updated: 2005-06-24

An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face

RecruitingNCT07729579

Sun Pharmaceutical Industries LimitedActinic Keratosis (AK)

Start: 2026-08-04End: 2026-12-01Target: 48Updated: 2026-08-13

Phase 2

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

CompletedNCT00034957

PfizerCarcinoma, Non-Small-Cell Lung, Lung Neoplasms

End: 2002-10-31Updated: 2012-02-16

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

TerminatedNCT00040391

Celgene CorporationColorectal Neoplasms, Diarrhea

Start: 2002-06-30Updated: 2016-12-01

Phase 3

The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

TerminatedNCT00006187

Merck Sharp & Dohme LLCAlzheimer Disease

End: 2005-06-30Updated: 2009-12-11

Active, not recruitingPACTR202111689978502

Jiangsu Recbio Technology Co LtdCOVID-19

Start: 2022-01-01Target: 2000Updated: 2026-08-03

Unknown Phase

I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis

Active, not recruitingNCT07186478

Hasanuddin UniversityHypoalbuminemia, Pulmonary Tuberculosis

Start: 2024-12-17End: 2025-10-20Target: 112Updated: 2025-09-22